Novo Suffers Loss in Lawsuit Against Pharmacy’s Copycat Ozempic
Novo Nordisk A/S failed to convince a federal judge that a pharmacy in Florida making compounded versions of its diabetes and ...
FiercePharma1d
'We cannot stay silent': Novo Nordisk flags dangers of compounded GLP-1s following Hims & Hers Super Bowl ad
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
What is compounded semaglutide and is it safe? The more affordable weight loss drugs Hims & Hers is selling, explained.
"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Ozempic and Blindness: What We Know About Weight Loss Side Effects
Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...
pharmaphorum15d
Novo aiming for blockbuster sales for FDA-approved semaglutide
Novo Nordisk’s weekly GLP-1 diabetes injection semaglutide ... year. Ozempic is approved for use in two therapeutic dosages, 0.5 mg and 1 mg, and will be launched in a special pen.
AOL9d
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
Ozempic and Wegovy helped Novo Nordisk increase their annual sales by $15 billion in the space of just two years following 2022 sales of $25 billion. However, its semaglutide patent begins to ...